Mexico: Growth For Health Cover, HMOs

29 September 1996

Health maintenance organizations are forecast to show rapid growth in Mexico's three largest cities, Mexico City, Monterrey and Guadalajara, following this year's reforms of the country's pensions and social security laws, says an article in Business Mexico.

While contributions to the social security institute, the IMSS, are now mandatory for employers, it is forecast that companies will soon be allowed to opt out; dissatisfaction with IMSS services means that already 90.7% of large and medium-sized firms offer private medical insurance as well, thus paying twice for their staff health care. Employers now pay a flat rate for all staff, but from 1998 contributions will vary based on income level.

Within three years, says Sergio Torres, a partner at insurer Brockman and Schuh, the IMSS will become more of a regulator than a provider, focusing mainly on ensuring that employers provide adequate cover for their staff, and only providing services for those who choose to remain within the IMSS or who have no other option.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight